首页> 外文期刊>Diabetes >Stimulation of GLP-1 Secretion Downstream of the Ligand-Gated Ion Channel TRPA1
【24h】

Stimulation of GLP-1 Secretion Downstream of the Ligand-Gated Ion Channel TRPA1

机译:配体门控离子通道TRPA1下游GLP-1分泌的刺激

获取原文
获取原文并翻译 | 示例
       

摘要

Stimulus-coupled incretin secretion from enteroendo-crine cells plays a fundamental role in glucose homeo-stasis and could be targeted for the treatment of type 2 diabetes. Here, we investigated the expression and function of transient receptor potential (TRP) ion channels in enteroendocrine L cells producing GLP-1. By microarray and quantitative PCR analysis, we identified trpa1 as an L cell-enriched transcript in the small intestine. Calcium imaging of primary L cells and the model cell line GLUTag revealed responses triggered by the TRPA1 agonists allyl-isothiocyanate (mustard oil), car-vacrol, and polyunsaturated fatty acids, which were blocked by TRPA1 antagonists. Electrophysiology in GLUTag cells showed that carvacrol induced a current with characteristics typical of TRPA1 and triggered the firing of action potentials. TRPA1 activation caused an increase in GLP-1 secretion from primary murine intestinal cultures and GLUTag cells, an effect that was abolished in cultures from trpa1~(-/-) mice or by pharmacological TRPA1 inhibition. These findings present TRPA1 as a novel sensory mechanism in enteroendocrine L cells, coupled to the facilitation of GLP-1 release, which may be exploitable as a target for treating diabetes.
机译:肠内分泌细胞的刺激性耦合肠降血糖素分泌在葡萄糖稳态中起着基本作用,可以作为治疗2型糖尿病的靶标。在这里,我们调查了产生GLP-1的肠内分泌L细胞中瞬时受体电位(TRP)离子通道的表达和功能。通过微阵列和定量PCR分析,我们确定trpa1为小肠中富含L细胞的转录本。初级L细胞和模型细胞系GLUTag的钙成像显示TRPA1激动剂烯丙基异硫氰酸酯(芥子油),香芹酚和多不饱和脂肪酸触发的反应被TRPA1拮抗剂阻断。 GLUTag细胞中的电生理学表明香芹酚可诱导具有TRPA1典型特征的电流并触发动作电位。 TRPA1激活导致原代小鼠肠道培养物和GLUTag细胞的GLP-1分泌增加,这种作用在trpa1〜(-/-)小鼠的培养物中或通过药理作用TRPA1抑制而被取消。这些发现表明TRPA1是肠内分泌L细胞中的一种新型感觉机制,与促进GLP-1释放有关,GLP-1的释放可以用作治疗糖尿病的靶标。

著录项

  • 来源
    《Diabetes》 |2015年第4期|1202-1210|共9页
  • 作者单位

    Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, U.K.;

    Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, U.K.;

    Wolfson Centre for Age-Related Diseases, King's College London, London, U.K.;

    Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, U.K.;

    Molecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, U.K.;

    Wolfson Centre for Age-Related Diseases, King's College London, London, U.K.;

    Institute of Physiology and Pathophysiology, University of Erlangen-Nuremberg, Erlangen, Germany;

    Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, U.K.;

    Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, U.K.;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:12

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号